News from Chiltern, AMRI and Cook Pharma – People on the move
Outsourcing-Pharma.com presents its weekly round-up of the latest xcareer movers in the world of pharmaceuticals including news from Chiltern, AMRI and Cook Pharma.
Archives for September 18, 2012
Lundbeck to stop making Elspar citing cost of securing API supply
Lundbeck has decided to stop making a cancer drug deeming the cost of securing API supplies too big and the likelihood to regulatory acceptance too small.
Recipharm gets OK in France
Swedish CDMO Recipharm has been cleared by French regulators to fill biotech drug products at its site in Tours.
Clinical trials should involve the elderly more, say experts
Geriatric patients are left out of trials too often say experts who want researchers to 'open their minds' to the benefits of recruiting the elderly.
More patient-centric formulations for the elderly, experts urge
New formulations and easier drug delivery methods could help elderly patients comply with treatments, experts say.
Pfizer inks generics CMO JV with Hisun
Pfizer and manufacturing partner Zhejiang Hisun Pharmaceuticals will set up a dedicated research centre to develop drugs for the Chinese market.